Inzlingen, Germany

Roland Jakob-Roetne

USPTO Granted Patents = 73 

 

 

Average Co-Inventor Count = 4.3

ph-index = 9

Forward Citations = 262(Granted Patents)

Forward Citations (Not Self Cited) = 245(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Inzlingen, DE (1989 - 2021)
  • Basel, CH (2020 - 2022)

Company Filing History:


Years Active: 1989-2022

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Phenoxytriazoles
Bicyclic Heteroaryl Derivatives
Bridged Piperidine Derivatives
Triazolopyridines
Fused Pyrimidine Derivatives
Neurogenic Agents
COMT Inhibitors
Isoquinoline Derivatives
Indole-Carboxamides
Benzimidazoles
Isoxazolo-Pyridine Derivatives
Thiazoles
73 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Roland Jakob-Roetne

Introduction: Roland Jakob-Roetne, a prolific inventor based in Inzlingen, Germany, has made significant strides in the field of pharmaceutical compounds, holding an impressive total of 73 patents. His work primarily focuses on compounds that may be utilized in the treatment of various neurological conditions, showcasing his dedication to addressing complex health issues through innovative solutions.

Latest Patents: Among Jakob-Roetne’s latest patents is a groundbreaking compound related to Phenoxytriazoles. This invention encompasses a compound of formula I, which features a five or six-membered heteroaryl group. The compounds described may serve as a treatment option for Alzheimer's disease, cerebral amyloid angiopathy, hereditary cerebral hemorrhage with amyloidosis, Dutch-type hereditary cerebral hemorrhage with amyloidosis, multi-infarct dementia, dementia pugilistica, and Down syndrome. Another notable patent involves bicyclic heteroaryl derivatives, highlighting compounds that exhibit similar treatment potential for various dementias and related conditions.

Career Highlights: Throughout his career, Roland Jakob-Roetne has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and Roche Palo Alto LLC. His contributions have been pivotal in the advancement of therapeutic compounds aimed at addressing critical health challenges.

Collaborations: Jakob-Roetne has collaborated with esteemed professionals in his field, including Alexander Flohr and Roger David Norcross. These partnerships have enhanced his research efforts and led to the development of innovative compounds that continue to influence therapeutic practices today.

Conclusion: Roland Jakob-Roetne stands out as a distinguished inventor, with his extensive portfolio of patents underscoring his commitment to innovation in pharmaceutical science. His work not only contributes to the scientific community but also holds the potential to improve the lives of individuals affected by debilitating neurological conditions. With a focus on research and development, Jakob-Roetne remains an inspiring figure in the world of inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…